Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2020 - Volume 24, Number 2
View All Articles in Issue

Abstract:  The study of intravenous admixture compatibility is an excellent application of “clinical pharmaceutics.” Clinical pharmaceutics involves the study and application of pharmaceutics and pharmaceutic (physical pharmacy/ chemistry) principles to clinical compounding situations to aid in the evaluation of each intravenous admixture. This series includes compatibility and stability considerations in intravenous admixture compounding. Part 2 of this series of articles discussed many factors that should be considered that may give rise to compatibility concerns, as well as drug sorption issues. In this issue (Part 3), there is a discussion on the methods and techniques that can be used to decrease the occurrence and incidence of incompatibilities, along with some alternate techniques to consider when some approaches do not seem feasible.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, intravenous drug admixtures, compatibility, incompatibilities, reconstitution timing, dilution factor, mixing, sorption, Y sites, concentration, complexation, light sensitivity, freezing, thawing, silicone oil, overfill

Related Categories: PARENTERALS, STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS

Printer-Friendly Version




Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Allen Loyd V Jr Mar/Apr 2020 121-126 Buy
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr Jan/Feb 2020 44-50 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence Nov/Dec 2021 446-462 Buy
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T Jan/Feb 2021 52-61 Buy
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr Jul/Aug 2021 311-317 Buy
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr May/Jun 2021 222-229 Buy
Compounding with Biotechnology Products, Part 2: Product-specific Considerations Allen Loyd V Jr Nov/Dec 2022 446-466 Buy
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Allen Loyd V Jr Nov/Dec 2020 473-478 Buy
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Allen Loyd V Jr May/Jun 2022 219-228 Buy